SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on July 28, 2009. The filing reports the consolidated financial results for the fourth quarter and the full fiscal year 2009, which ended on May 31, 2009. The detailed results are contained in a press release attached as Exhibit 99.1.
Note: The input metadata references "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as "LANDEC CORPORATION". This summary reflects the entity named in the filing text.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being included in the attached press release (Exhibit 99.1), which is not part of the provided input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms that results for the fourth quarter and fiscal year 2009 were announced.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. The document serves solely as a notification that the results have been issued and the press release is incorporated by reference.
Investor Verification Checklist
- Verify the specific revenue and net income figures for Q4 and FY 2009 in the attached Exhibit 99.1 press release.
- Confirm the company name discrepancy between the metadata (Lifecore Biomedical) and the filing (Landec Corporation).
- Review the full press release for any non-GAAP reconciliations or segment performance details not summarized in the 8-K.
- Check for any subsequent filings that may update the financial condition or provide additional context to the July 28, 2009 announcement.